Prudence Multi-Strategy SPC – Credit SP was awarded the ‘2023 Offshore Chinese Fund of the Year Award’

The "Offshore China Fund Awards 2023" list was officially announced at the Four Seasons Hotel in Hong Kong on 21st March 2024. Prudence Multi-Strategy SPC-Credit SP won the first place in the "Best Credit Hedge Fund (3 Years)" category.

继续阅读Prudence Multi-Strategy SPC – Credit SP was awarded the ‘2023 Offshore Chinese Fund of the Year Award’

Winner! HFM Asian Performance Awards 2021

Prudence Multi-Strategy SPC- Credit SP won the HFM Asia Performance Awards 2021 New Fund of the Year! The HFM Asia Performance Awards have been established by bringing together the two leading hedge fund awards in the region. The HFM AsiaHedge Awards and Eurekahedge Asia Awards are the most important and respected awards in the Asian hedge fund calendar and have been rewarding the finest in the industry since 2004.

继续阅读Winner! HFM Asian Performance Awards 2021

Ms Yang Xi Presented at the 2023 virtual investment strategy conference

Everbright Securities organised the 2023 annual investment strategy conference "New Era, New Pattern, New Journey" in December 2022. Ms. Yang Xi was invited to attend the overseas TMT sub-forum. As a keynote speaker, she shared her views about the investment opportunities for hedge funds in the global market in 2023. During the conference, she also shared how to navigate in volatile market conditions and her views on the global investment opportunities for the upcoming year.

继续阅读Ms Yang Xi Presented at the 2023 virtual investment strategy conference

Ms Yang Xi Presented at the Chinese Offshore Bonds Global Summit 2022

Chongwa (Macau) Financial Asset Exchange (MOX), 97 Duration Finance and Century Securities organised the Chinese Offshore Bonds Global Summit 2022 on 13th December. Ms. Yang Xi was invited to participate as a keynote speaker. During the forum, she mentioned the diversity of offshore bonds in the free trade zone and analysed the buyer’s considerations for investing in offshore bonds.

继续阅读Ms Yang Xi Presented at the Chinese Offshore Bonds Global Summit 2022

Winner! Best Private Fund for Bond Strategy (5 years) 2021

Prudence Enhanced Income Master Fund won the Best Private Fund for Bond Strategy (5 years)! Winners are assessed based on qualitative and quantitative criteria, with a strong focus on performance. Among the 56822 funds, Prudence Enhanced Income Master Fund emerged as the top fund and won the award.

继续阅读Winner! Best Private Fund for Bond Strategy (5 years) 2021

Mr Chad Liu, Chairman of Prudence Financial Group, was invited as a guest speaker for the Goldman Sachs Asia Hedge Fund Symposium

The 23rd Annual Goldman Sachs Asia Hedge Fund Symposium successfully concluded in Singapore on 28th September. Mr. Chad Liu, Chairman of Prudence Financial Group, was invited to participate as a guest speaker. The Symposium is an in-person hedge fund conference in Asia. It was attended by global institutional investors from America, Europe, Asia, and other regions. Mr. Chad Liu was a speaker for the lunch panel “Optimising Alpha in Asia Pacific Across Asset Classes”. He shared his views on the alpha opportunities in the credit markets in Asia.

继续阅读Mr Chad Liu, Chairman of Prudence Financial Group, was invited as a guest speaker for the Goldman Sachs Asia Hedge Fund Symposium

Ms. Linlin Ma Presented at Bank of America 2022 APAC Financial, Real Estate Equity and Credit Conference, May 2022

On May 12, 2022, BofA Securities hosted the 2022 APAC Financial, Real Estate Equity and Credit Conference. Ms. Linlin Ma of Prudence presented as a guest speaker to share her views on the China property HY bonds at the panel “China property HY bonds: distressed opportunities and challenges “.

继续阅读Ms. Linlin Ma Presented at Bank of America 2022 APAC Financial, Real Estate Equity and Credit Conference, May 2022

投资动态| 晶泰科技获得超3亿美元融资,打造AI药物研发新基建

2020 年9 月28 日消息,以数位化和智慧化驱动的人工智慧(AI)药物研发公司晶泰科技(XtalPi) 宣布超额完成3.188 亿美元的C 轮融资,创造全球AI药物研发领域融资额的最高纪录。

继续阅读投资动态| 晶泰科技获得超3亿美元融资,打造AI药物研发新基建

生态圈|晶泰科技获选生物医药科技「Fierce 15」权威榜单

2022年3月7日,美国知名生物科技媒体Fierce Medtech公布了Fierce 15-医药科技「勇猛15」榜单,晶泰科技作为行业领先的AI制药企业上榜,获选2021年最有权力的15家医药科技公司,这也是近年来中国本土企业首次获得这一奖项。

继续阅读生态圈|晶泰科技获选生物医药科技「Fierce 15」权威榜单